Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04612322 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

MICRO: a Registry Study in Patients With Microvascular Angina

Study acronym: MICRO
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 31, 2022 (before its estimated October 10, 2024 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Oct 10, 2022 to Oct 10, 2024
    • Study completion date: Oct 10, 2027 to Oct 10, 2029
    v3
  2. Study title revisedv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The evidence above demonstrates that microvascular dysfunction is an important determinant of patient prognosis, which however remains poorly classified. Given the high burden of disease and the severity of the functional impairment in these patients, the lack of a clear definition for this disease has a potentially large clinical importance. It is important to better describe the phenotype of these patients, identify the predictors of prognosis, and determine the impact of diagnosis.
Trial Details
NCT Number NCT04612322
Lead Sponsor Johannes Gutenberg University Mainz
Conditions
(from sponsor)		 Microvascular Disease
Related terms Angina Pectoris, Coronary Artery Disease
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov